Hanieh, P.N.; Consalvi, S.; Forte, J.; Cabiddu, G.; De Logu, A.; Poce, G.; Rinaldi, F.; Biava, M.; Carafa, M.; Marianecci, C.
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment. Pharmaceutics 2022, 14, 610.
https://doi.org/10.3390/pharmaceutics14030610
AMA Style
Hanieh PN, Consalvi S, Forte J, Cabiddu G, De Logu A, Poce G, Rinaldi F, Biava M, Carafa M, Marianecci C.
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment. Pharmaceutics. 2022; 14(3):610.
https://doi.org/10.3390/pharmaceutics14030610
Chicago/Turabian Style
Hanieh, Patrizia Nadia, Sara Consalvi, Jacopo Forte, Gianluigi Cabiddu, Alessandro De Logu, Giovanna Poce, Federica Rinaldi, Mariangela Biava, Maria Carafa, and Carlotta Marianecci.
2022. "Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment" Pharmaceutics 14, no. 3: 610.
https://doi.org/10.3390/pharmaceutics14030610
APA Style
Hanieh, P. N., Consalvi, S., Forte, J., Cabiddu, G., De Logu, A., Poce, G., Rinaldi, F., Biava, M., Carafa, M., & Marianecci, C.
(2022). Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment. Pharmaceutics, 14(3), 610.
https://doi.org/10.3390/pharmaceutics14030610